US Broker Ratings

Centene Corporation (CNC) Stock Analysis: Navigating the Healthcare Sector’s Dynamic Terrain

Centene Corporation (NYSE: CNC) stands as a formidable player in the healthcare plans industry, with a robust market capitalization of $29.2 billion. Headquartered in Saint Louis, Missouri, Centene provides a..

Universal Health Services, Inc. (UHS): Investor Outlook with a Compelling 40.33% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands as a significant player within the healthcare sector, specifically within the medical care facilities industry. Headquartered in King of Prussia, Pennsylvania, UHS has..

Exelixis, Inc. (EXEL) Stock Analysis: Strong Revenue Growth Amidst Biotechnology Innovations

Exelixis, Inc. (NASDAQ: EXEL) stands as a prominent player in the biotechnology sector, with a market capitalization of $12.61 billion. Headquartered in Alameda, California, the company has carved a niche..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant with a 29.80% Upside Potential

Cencora, Inc. (NYSE: COR), a leading player in the healthcare sector’s medical distribution industry, has been catching the eye of investors with its impressive market performance and promising growth potential...

West Pharmaceutical Services, Inc. (WST) Stock Analysis: A Healthcare Giant with Notable Growth Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, is a company that has consistently captured the attention of investors seeking reliable growth and robust market..

Revvity, Inc. (RVTY) Stock Analysis: A Blend of Healthcare Innovation and Notable Growth Potential

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry. Headquartered in Waltham, Massachusetts, and boasting a market capitalization of $10.82..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating a 36% Potential Upside with Robust Analyst Confidence

Thermo Fisher Scientific Inc (NYSE: TMO), a stalwart in the healthcare sector, stands out as a compelling investment opportunity with a notable 36.42% potential upside, as indicated by the average..

Genmab A/S (GMAB) Investor Outlook: 39.73% Potential Upside Beckons Amid Strong Revenue Growth

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, is capturing investor attention with its compelling growth metrics and a notable potential upside. With a market capitalization of..

Solventum Corporation (SOLV) Stock Report: Is a 6.83% Upside Worth the Dive?

Solventum Corporation (SOLV), a prominent player in the healthcare sector, has been drawing attention with its diverse portfolio spanning Medsurg, Dental Solutions, and Health Information Systems. With a market capitalization..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring Its 8.72% Upside and Strategic Biopharma Investments

Royalty Pharma plc (NASDAQ: RPRX) continues to capture investor interest as a unique entity in the healthcare sector, specifically within the biotechnology industry. Based in New York City and boasting..

Insmed Incorporated (INSM) Stock Analysis: Unveiling an 88.25% Potential Upside in Biotech Innovation

Investors keeping an eye on the healthcare sector, particularly biotechnology, may find Insmed Incorporated (NASDAQ: INSM) an intriguing opportunity. With a market capitalization of $23.03 billion, Insmed stands as a..

GSK plc (GSK) Stock Analysis: Attractive 12.23% Potential Upside Amid Strong Dividend Yield

Investors eyeing opportunities in the healthcare sector might find GSK plc (GSK) a compelling case, with its robust market presence and promising growth potential. Headquartered in London, GSK sits prominently..

Stryker Corporation (SYK) Stock Analysis: A Medical Device Leader with a 23% Upside Potential

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector known for its innovative medical devices, is capturing investor attention with a noteworthy potential upside of 23.02%. As the company..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating Its 5.89% Upside Potential

For individual investors eyeing opportunities in the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling case with its robust market presence and promising potential upside. With a market..

Incyte Corporation (INCY) Stock Analysis: Unlocking an 11% Upside with Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY) stands tall in the biotechnology industry, a sector known for its innovation and rapid growth. With a market capitalization of $19.41 billion, Incyte is a notable..

Danaher Corporation (DHR) Investor Outlook: Evaluating a 44% Potential Upside

For investors eyeing opportunities in the healthcare sector, Danaher Corporation (NYSE: DHR) presents a noteworthy consideration. With a market capitalization of approximately $121.74 billion, Danaher is strategically positioned in the..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: A Precision Instrument Powerhouse with 20% Upside Potential

Mettler-Toledo International, Inc. (NYSE: MTD) is a prominent player in the diagnostics and research industry, offering a wide array of precision instruments and services. Headquartered in Greifensee, Switzerland, the company..

IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Unveiling a 26.78% Potential Upside in the Diagnostics Arena

Investors with an eye on the healthcare sector should consider IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the diagnostics and research industry with a particular focus on animal..

AstraZeneca PLC (AZN) Stock Analysis: Strong Buy Ratings and a 20% Upside Potential

AstraZeneca PLC (NASDAQ: AZN), a prominent player in the healthcare sector, stands as a titan among global drug manufacturers. With a market capitalization of $290.06 billion, this UK-based biopharmaceutical company..

Medtronic plc (MDT) Stock Analysis: Exploring a 36% Potential Upside for Investors

Medtronic plc (NYSE: MDT), a titan in the medical devices industry, is capturing investor attention with a substantial potential upside of 36.23%. This renowned company, headquartered in Galway, Ireland, operates..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds